These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular Characterization of Bladder Cancer in Smokers versus Nonsmokers. Joshi M; Millis SZ; Arguello D; Holder SL; Lamm D; Reddy S; Belani C; Drabick JJ; Vogelzang NJ Eur Urol Focus; 2018 Jan; 4(1):94-97. PubMed ID: 28753770 [TBL] [Abstract][Full Text] [Related]
5. Intravascular release of a platelet-activating factor-like lipid (PAF-LL) induced by cigarette smoking. Imaizumi T Lipids; 1991 Dec; 26(12):1269-73. PubMed ID: 1840278 [TBL] [Abstract][Full Text] [Related]
6. FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy. Kompier LC; Lurkin I; van der Aa MN; van Rhijn BW; van der Kwast TH; Zwarthoff EC PLoS One; 2010 Nov; 5(11):e13821. PubMed ID: 21072204 [TBL] [Abstract][Full Text] [Related]
7. Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers. Huang ZM; Chen HA; Chiang YT; Shen CH; Tung MC; Juang GD J Chin Med Assoc; 2014 Feb; 77(2):83-8. PubMed ID: 24315573 [TBL] [Abstract][Full Text] [Related]
8. Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens. Wallerand H; Bakkar AA; de Medina SG; Pairon JC; Yang YC; Vordos D; Bittard H; Fauconnet S; Kouyoumdjian JC; Jaurand MC; Zhang ZF; Radvanyi F; Thiery JP; Chopin DK Carcinogenesis; 2005 Jan; 26(1):177-84. PubMed ID: 15347601 [TBL] [Abstract][Full Text] [Related]
9. Effect of cigarette smoking on the levels of platelet-activating factor-like lipid(s) in plasma lipoproteins. Imaizumi T; Satoh K; Yoshida H; Kawamura Y; Hiramoto M; Takamatsu S Atherosclerosis; 1991 Mar; 87(1):47-55. PubMed ID: 1872924 [TBL] [Abstract][Full Text] [Related]
10. TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region. Pakmanesh H; Anvari O; Forey N; Weiderpass E; Malekpourafshar R; Iranpour M; Shahesmaeili A; Ahmadi N; Bazrafshan A; Zendehdel K; Kannengiesser C; Ba I; McKay J; Zvereva M; Hosen MI; Sheikh M; Calvez-Kelm FL Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430798 [TBL] [Abstract][Full Text] [Related]
12. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers. Imaizumi T; Satoh K; Yoshida H; Kawamura Y; Hiramoto M; Koyanagi M; Takamatsu S; Takamatsu M Heart Vessels; 1990; 5(2):81-6. PubMed ID: 2354992 [TBL] [Abstract][Full Text] [Related]
13. Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patients. Fantini D; Seiler R; Meeks JJ Urol Oncol; 2019 Nov; 37(11):818-825. PubMed ID: 30446446 [TBL] [Abstract][Full Text] [Related]
14. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer. Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733 [TBL] [Abstract][Full Text] [Related]
15. Smoking intensity and bladder cancer aggressiveness at diagnosis. Barbosa ALA; Vermeulen SHHM; Aben KK; Grotenhuis AJ; Vrieling A; Kiemeney LA PLoS One; 2018; 13(3):e0194039. PubMed ID: 29570711 [TBL] [Abstract][Full Text] [Related]
16. Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway. Hektoen HH; Robsahm TE; Andreassen BK; Stenehjem JS; Axcrona K; Mondul A; Gislefoss RE Cancer Med; 2020 Jun; 9(12):4420-4432. PubMed ID: 32319230 [TBL] [Abstract][Full Text] [Related]
17. Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up. Critelli R; Fasanelli F; Oderda M; Polidoro S; Assumma MB; Viberti C; Preto M; Gontero P; Cucchiarale G; Lurkin I; Zwarthoff EC; Vineis P; Sacerdote C; Matullo G; Naccarati A Oncotarget; 2016 Oct; 7(41):67435-67448. PubMed ID: 27611947 [TBL] [Abstract][Full Text] [Related]
18. Whole blood aggregation and plasma lyso-PAF related to smoking and atherosclerosis. Sturm MJ; Strophair JM; Kendrew PJ; Vandongen R; Beilin LJ; Taylor RR Clin Exp Pharmacol Physiol; 1989 Jul; 16(7):597-605. PubMed ID: 2805433 [TBL] [Abstract][Full Text] [Related]
19. BER gene polymorphisms associated with key molecular events in bladder cancer. Smal MP; Kuzhir TD; Savina NV; Nikitchenko NV; Rolevich AI; Krasny SA; Goncharova RI Exp Oncol; 2018 Dec; 40(4):288-298. PubMed ID: 30593754 [TBL] [Abstract][Full Text] [Related]
20. Tar, nicotine and carbon monoxide yield of UK cigarettes and the risk of non-muscle-invasive and muscle-invasive bladder cancer. van Osch FHM; Pauwels CGGM; Jochems SHJ; Fayokun R; James ND; Wallace DMA; Cheng KK; Bryan RT; van Schooten FJ; Zeegers MP Eur J Cancer Prev; 2019 Jan; 28(1):40-44. PubMed ID: 28683008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]